Fever and signs of shock. The essential dangerous fever

Emergency Medicine Clinics of North America

Volumn 31, Issue 4, 2013, Pages 907-926

  Reifel Saltzberg, Jennifer M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Early goal directed therapy; Resuscitation; Sepsis; Sepsis bundles; Septic shock; Severe sepsis

Indexed keywords

ACTIVATED PROTEIN C; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; CD4 ANTIGEN; CHLORHEXIDINE GLUCONATE; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; DROTRECOGIN; ERYTHROPOIETIN; FRESH FROZEN PLASMA; GLUCOSE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 4; LACTIC ACID; MACROLIDE; NITRIC OXIDE; NORADRENALIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VASOPRESSIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG FATALITY; EARLY DIAGNOSIS; ECHOGRAPHY; FEVER; FLUID RESUSCITATION; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PRELOAD; HEMODYNAMIC MONITORING; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INCIDENCE; LOW DRUG DOSE; MESENTERIC ISCHEMIA; MORTALITY; ORGAN PERFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SKIN NECROSIS; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS INFECTION;

EARLY GOAL-DIRECTED THERAPY; RESUSCITATION; SEPSIS; SEPSIS BUNDLES; SEPTIC SHOCK; SEVERE SEPSIS;

ANTI-BACTERIAL AGENTS; EARLY DIAGNOSIS; EMERGENCY SERVICE, HOSPITAL; FEVER; HUMANS; RESUSCITATION; SHOCK, SEPTIC;

EID: 84886592151     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.emc.2013.07.009     Document Type: Review

References (80)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Brun-Buisson C., Meshaka P., Pinton P., The EPISEPSIS Study Group EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580-588.
3. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. NEngl J Med 2003, 348:1546-1554.
4. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEngl J Med 2001, 345:1368-1377.
5. Shorr A.F., Micek S.T., Jackson W.L., et al. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?. Crit Care Med 2007, 35:1257-1262.
6. Kumar A., Roberts D., Wood K., et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
7. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
8. Wang H.E., Shapiro N.I., Angus D.C., et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007, 35:1928-1936.
9. Levy M.M., Dellinger R.P., Townsend S.R., et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010, 36:222-231.
10. Wang H.E., Devereaux R.S., Yealy D.M., et al. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr 2010, 9:9.
11. Peake S.L., Bailey M., Bellomo R., et al. Australasian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study. Resuscitation 2009, 80:811-818.
12. Castellanos-Ortega A., Suberviola B., García-Astudillo L.A., et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 2010, 38:1036-1043.
13. Carrillo-Esper R., Carrillo-Córdova J.R., Carrillo-Córdova L.D. Epidemiological study of sepsis in Mexican intensive care units. Cir Cir 2009, 77:301-308. [in English, Spanish].
14. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. NEngl J Med 2003, 348:138-150.
15. Ait-Oufella H., Maury E., Lehoux S., et al. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med 2010, 36:1286-1298.
16. Spronk P.E., Zandstra D.F., Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004, 8:462-468.
17. Romero-Bermejo F.J., Ruiz-Bailen M., Gil-Cebrian J., et al. Sepsis-induced cardiomyopathy. Curr Cardiol Rev 2011, 7:163-183.
18. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
19. Glickman S.W., Cairns C.B., Otero R.M., et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 2010, 17:383-390.
20. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
21. Levy M.M., Fink M.P., Marshall J.C., SCCM/ESICM/ACCP/ATS/SIS, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
22. Girard T.D., Opal S.M., Ely E.W. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis 2005, 40:719-727.
23. Ferreira F.L., Bota D.P., Bross A., et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758.
24. Cardoso T., Henriques Carneiro A., Ribeiro O., et al. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 2010, 14:R83.
25. Silva E., Pedro M.A., Sogayar A.C., et al. Brazilian sepsis epidemiological study (BASES study). Crit Care 2004, 8:R251-R260.
26. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677.
27. Puskarich M.A., Trzeciak S., Shapiro N.I., Emergency Medicine Shock Research Network (EMSHOCKNET), et al. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation 2011, 82:1289-1293.
28. Howell M.D., Donnino M., Clardy P., et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007, 33:1892-1899.
29. Carcillo J.A., Fields A.I. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002, 30:1365-1378.
30. Alam F.F., Mustafa A.S., Khan Z.U. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007, 7:103.
31. Pemán J., Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 2009, 53:424-433.
32. Schuetz P., Chiappa V., Briel M., et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011, 171:1322-1331.
33. Nobre V., Harbarth S., Graf J.D., et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177:498-505.
34. Heyland D.K., Johnson A.P., Reynolds S.C., et al. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 2011, 39:1792-1799.
35. Francis M., Rich T., Williamson T., et al. Effect of an emergency department sepsis protocol on time to antibiotics in severe sepsis. CJEM 2010, 12:303-310.
36. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
37. Vallés J., Rello J., Ochagavía A., et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003, 123:1615-1624.
38. Capp R., Chang Y., Brown D.F. Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?. JEmerg Med 2011, 41:573-580.
39. Cheng A.C., West T.E., Limmathurotsakul D., et al. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 2008, 5:e175.
40. Marik P.E. Surviving sepsis: going beyond the guidelines. Ann Intensive Care 2011, 1:17.
41. Perner A., Haase N., Guttormsen A.B., Scandinavian Critical Care Trials Group, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. NEngl J Med 2012, 367:124-134.
42. Guidet B., Martinet O., Boulain T., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012, 16:R94.
43. Myburgh J.A., Finfer S., Bellomo R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. NEngl J Med 2012, 367:1901-1911.
44. Delaney A.P., Dan A., McCaffrey J., et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011, 39:386-391.
45. Cannon C.M., Holthaus C.V., Zubrow M.T., et al. The GENESIS Project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. JIntensive Care Med 2012, 10.1177/0885066612453025.
46. Shujaat A., Bajwa A.A. Optimization of preload in severe sepsis and septic shock. Crit Care Res Pract 2012, 2012:761051.
47. Cavallaro F., Sandroni C., Marano C., et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and meta-analysis of clinical studies. Intensive Care Med 2010, 36:1475-1483.
48. Vasu T.S., Cavallazzi R., Hirani A., et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. JIntensive Care Med 2012, 27:172-178.
49. De Backer D., Aldecoa C., Njimi H., et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012, 40:725-730.
50. Russell J.A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011, 15:226.
51. Russell J.A., Walley K.R., Singer J., VASST Investigators, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. NEngl J Med 2008, 358:877-887.
52. Vieillard-Baron A., Caille V., Charron C., et al. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008, 36:1701-1706.
53. Gattinoni L., Brazzi L., Pelosi P., et al. Atrial of goal-oriented hemodynamic therapy in critically ill patients. NEngl J Med 1995, 333:1025-1032.
54. Vincent J.L., Rhodes A., Perel A., et al. Clinical review: update on hemodynamic monitoring-a consensus of 16. Crit Care 2011, 15:229.
55. Reinhart K., Rudolph T., Bredle D.L., et al. Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. Chest 1989, 95:1216-1221.
56. Pope J.V., Jones A.E., Gaieski D.F., Emergency Medicine Shock Research Network (EMShock Net) Investigators, et al. Multicenter study of central venous oxygen saturation (ScvO2) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010, 55:40-46.
57. Textoris J., Fouché L., Wiramus S., et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care 2011, 15:R176.
58. Shapiro N.I., Howell M.D., Talmor D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005, 455:524-528.
59. Jones A.E., Shapiro N.I., Trzeciak S., et al. Clinical trial as goals of early sepsis therapy: a randomized lactate clearance vs central venous oxygen saturation. JAMA 2010, 303:739-746.
60. Karon B.C., Scott R., Burritt M.F., et al. Comparison of lactate values between point-of-care and central laboratory analyzers. Am J Clin Pathol 2007, 128:168-171.
61. Tanner R.K., Fuller K.L., Ross M.L. Evaluation of three portable blood lactate analysers: lactate pro, lactate scout and lactate plus. Eur J Appl Physiol 2010, 109:551-559.
62. Moyo S., Bussmann H., Mangwendeza P., et al. Validation of a point-of-care lactate device for screening at-risk adults receiving combination antiretroviral therapy in Botswana. JAntivir Antiretrovir 2011, 3:45-48.
63. Puskarich M.A., Trzeciak S., Shapiro N.I., et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med 2012, 19:252-258.
64. Dell'Aglio D.M., Perino L.J., Kazzi Z., et al. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 2009, 54:818-823.
65. Perel A. Bench-to-bedside review: the initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines-does one size fit all?. Crit Care 2008, 12:223.
66. Via G., Storti E., Spreafico A., et al. Point of care ultrasound for sepsis management in resource-limited settings: time for a new paradigm for global health care. Intensive Care Med 2012, 38:1405-1407.
67. Haydar S.A., Moore E.T., Higgins G.L., et al. Effect of bedside ultrasonography on the certainty of physician clinical decisionmaking for septic patients in the emergency department. Ann Emerg Med 2012, 60:346-358.
68. Shah S., Noble V.E., Umulisa I., et al. Development of an ultrasound training curriculum in a limited resource international setting: successes and challenges of ultrasound training in rural Rwanda. Int J Emerg Med 2008, 1(3):193-196.
69. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301:2362-2375.
70. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. NEngl J Med 2008, 358:111-124.
71. Bernard G.R., Vincent J.L., Laterre P.F., Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. NEngl J Med 2001, 344:699-709.
72. Dellinger R.P., Levy M.M., Carlet J.M., for the International Surviving Sepsis Campaign Guidelines Committee, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 36:296-327.
73. Ranieri V.M., Thompson B.T., Barie P.S., PROWESS-SHOCK Study Group, et al. Drotrecogin alfa (activated) in adults with septic shock. NEngl J Med 2012, 366:2055-2064.
74. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. NEngl J Med 2005, 353:1685-1693.
75. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. NEngl J Med 2001, 345:1359-1367.
76. The NICE-SUGAR Study Investigators, Finfer S., Liu B., et al. Hypoglycemia and risk of death in critically ill patients. NEngl J Med 2012, 367:1108-1118.
77. Jones A.E., Shapiro N.I., Roshon M. Implementing early goal-directed therapy in the emergency setting: the challenges and experiences of translating research innovations into clinical reality in academic and community settings. Acad Emerg Med 2007, 14:1072-1078.
78. Nguyen H.B., Lynch E.L., Mou J.A., et al. The utility of a quality improvement bundle in bridging the gap between research and standard care in the management of severe sepsis and septic shock in the emergency department. Acad Emerg Med 2007, 14:1079-1086.
79. Nguyen H.B., Corbett S.W., Steele R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007, 35:1105-1112.
80. Casserly B., Baram M., Walsh P., et al. Implementing a collaborative protocol in a sepsis intervention program: lessons learned. Lung 2011, 189:11-19.